Skip to main content
ZTS logo
ZTS
(NYSE)
Zoetis Inc.
$73.54-- (--)
Loading... - Market loading

Zoetis (ZTS) Stock Price & Financial Analysis

Zoetis Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$71.99 - $74.39
52-Week High$160.48
52-Week Low$71.45
Open$74.39
Volume6.92M
Average Volume (3M)6.47M
Market Cap31.06B
Shares Outstanding422.40M
P/E Ratio (TTM)11.61
Forward P/E11.32
Price to Sales (P/S)3.23
Price to Book (P/B)9.49
EV/EBITDA9.44
Revenue (TTM)9.51B
Net Income (TTM)2.64B
Free Cash Flow (TTM)2.24B
EPS (TTM)$6.04
Profit Margin27.79%
Operating Margin37.57%
Return on Equity (ROE)81.75%
Debt to Equity2.86
50-Day MA$76.65
200-Day MA$108.41
52-Week Change-50.69%
Annual Dividend$2.09
Dividend Yield2.88%
Payout Ratio34.59%
Last Dividend Ex-DateJul 20, 2026

Frequently Asked Questions About Zoetis

What is the current stock price for ZTS?

As of the latest trading session, ZTS stock trades at $73.54. The 52-week range is $71.45–$160.48, with a day range of $71.99–$74.39.

What is the P/E ratio for ZTS?

Zoetis's trailing P/E ratio is 11.6, meaning investors pay $11.6 for every $1 of annual earnings. The forward P/E is 11.3, reflecting analyst expectations for future earnings. Zoetis operates in the Healthcare sector.

Does ZTS pay dividends?

Yes, Zoetis pays a 2.88% annual dividend yield ($2.09 per share). The payout ratio is 34.6%. The last ex-dividend date was 2026-07-20.

What do analysts recommend for ZTS?

Based on 9 analysts, the consensus for ZTS is Buy.

What is the market cap of ZTS?

Zoetis's market capitalization is $31.06B, classifying it as a large-cap company. Zoetis operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.